< Back to Article

Early exposure to broadly neutralizing antibodies may trigger a dynamical switch from progressive disease to lasting control of SHIV infection

Table 1

Model parameters fixed from previous studies.

doi: https://doi.org/10.1371/journal.pcbi.1008064.t001